msp3-crm-vac4all
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2021 (NCT05197751)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05776017 | Phase 1/Phase 2 (Phase 2) | Mar 27, 2023 | Malaria Research and Training Center, Bamako, Mali, Vac4All |
| NCT05197751 | Phase 1 | Dec 1, 2021 | Vac4All |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vac4All | Academic/Hospital | 2 | 2 | 2 | 2021 |
| Malaria Research and Training Center, Bamako, Mali | Academic/Hospital | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1